NASDAQ: MLTX · Health Care / Biotechnology: Pharmaceutical Preparations

MoonLake Immunotherapeutics

How MoonLake Immunotherapeutics compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$1.1B
Price
$12.57
P/E
-4.1
EPS (TTM)
$-3.10
1-year return
30.8%
Dividend yield
0.0%
52-week range
$9.55–$13.00

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources